Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	1,138	964.2	2,674	1,919	826.64
Short-Term Investments	-	126.74	116.55	16.33	54.9	-
Trading Asset Securities	-	4,029	3,596	1,019	1,213	1,235
Cash & Short-Term Investments	5,070	5,293	4,676	3,709	3,187	2,062
Cash Growth	8.36%	13.18%	26.07%	16.38%	54.57%	53.82%
Accounts Receivable	-	985.68	1,003	884.91	872.31	755.29
Other Receivables	-	15.9	20.06	63.54	23.55	21.3
Receivables	-	1,003	1,025	949.31	896.59	777.32
Inventory	-	1,485	1,240	1,209	938.81	800.3
Prepaid Expenses	-	39.63	23.23	20.97	19.66	22.46
Other Current Assets	-	277.9	257.09	155.55	117.89	141.92
Total Current Assets	-	8,097	7,221	6,044	5,160	3,804
Property, Plant & Equipment	-	3,073	2,888	2,718	2,510	2,143
Long-Term Investments	-	1.71	1.7	0.7	0.7	0.67
Goodwill	-	3,253	3,209	2,961	2,887	2,941
Other Intangible Assets	-	582.86	608.78	663.06	746.74	645.44
Long-Term Deferred Tax Assets	-	142.82	113.42	74.2	68.68	74.24
Other Long-Term Assets	-	203.84	176.73	215.04	187.96	154.45
Total Assets	-	15,355	14,218	12,676	11,562	9,786
Accounts Payable	-	157.59	242.21	178.97	152.17	96.42
Accrued Expenses	-	141.97	124.55	124.62	121.28	106.37
Short-Term Debt	-	175.8	49.89	19.2	46.92	127.4
Current Portion of Long-Term Debt	-	3.58	1.96	5.99	42.93	29.25
Current Portion of Leases	-	65.54	59.37	57.28	51.89	57.32
Current Income Taxes Payable	-	91.41	14.84	1.99	1.89	4.13
Other Current Liabilities	-	427.68	282.84	216.17	258.48	229.34
Total Current Liabilities	-	1,064	775.66	604.22	675.56	650.23
Long-Term Debt	-	66.52	72.77	73.53	93.16	41.08
Long-Term Leases	-	161.64	151	191.3	44.73	78.75
Long-Term Deferred Tax Liabilities	-	343.24	372.27	392.5	408.5	328.55
Other Long-Term Liabilities	-	1.71	0.93	3.1	3.69	1.85
Total Liabilities	-	1,644	1,377	1,272	1,236	1,112
Common Stock	-	223.65	223.65	223.6	223.46	223.36
Additional Paid-In Capital	-	821.31	821.31	813.55	789.56	772.98
Retained Earnings	-	10,711	9,945	9,022	8,016	6,613
Comprehensive Income & Other	-	1,485	1,360	826.43	680.3	786.88
Total Common Equity	13,417	13,241	12,351	10,886	9,709	8,397
Minority Interest	-	469.52	491.02	517.93	616.82	277.95
Shareholders' Equity	13,888	13,711	12,842	11,404	10,326	8,674
Total Liabilities & Equity	-	15,355	14,218	12,676	11,562	9,786
Total Debt	469.18	473.08	334.99	347.3	279.63	333.8
Net Cash (Debt)	4,601	4,820	4,341	3,362	2,908	1,728
Net Cash Growth	7.24%	11.02%	29.13%	15.63%	68.25%	74.52%
Net Cash Per Share	41.06	43.08	38.83	30.05	25.99	15.46
Filing Date Shares Outstanding	112.04	111.82	111.82	111.8	111.73	111.68
Total Common Shares Outstanding	112.04	111.82	111.82	111.8	111.73	111.68
Working Capital	-	7,034	6,445	5,440	4,485	3,154
Book Value Per Share	120.14	118.41	110.45	97.37	86.90	75.18
Tangible Book Value	9,575	9,405	8,533	7,262	6,075	4,810
Tangible Book Value Per Share	85.74	84.11	76.31	64.96	54.38	43.07
Land	-	568.36	559.12	517.39	517.39	469.99
Buildings	-	730.58	723.47	627.92	587.94	358.23
Machinery	-	2,666	2,500	2,342	2,165	1,825
Construction In Progress	-	307.37	156.09	96.28	48.62	47.57
Leasehold Improvements	-	126.51	115.34	103.32	102.46	102.23

Source: S&P Capital IQ. Standard template. Financial Sources.